Single-cell profiling reveals heterogeneity and functional patterning of GPCR expression in the vascular system

[1]  Ruben Abagyan,et al.  Identifying ligands at orphan GPCRs: current status using structure‐based approaches , 2016, British journal of pharmacology.

[2]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[3]  R. Bonecchi,et al.  Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response , 2016, Front. Immunol..

[4]  Kenneth A Jacobson,et al.  New paradigms in GPCR drug discovery. , 2015, Biochemical pharmacology.

[5]  David J. Arenillas,et al.  JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles , 2015, Nucleic Acids Res..

[6]  Hans Clevers,et al.  Single-cell messenger RNA sequencing reveals rare intestinal cell types , 2015, Nature.

[7]  P. Fadel,et al.  Adrenergic and non-adrenergic control of active skeletal muscle blood flow: Implications for blood pressure regulation during exercise , 2015, Autonomic Neuroscience.

[8]  Fabian J Theis,et al.  Computational analysis of cell-to-cell heterogeneity in single-cell RNA-sequencing data reveals hidden subpopulations of cells , 2015, Nature Biotechnology.

[9]  P. Kharchenko,et al.  Bayesian approach to single-cell differential expression analysis , 2014, Nature Methods.

[10]  J. Gutkind,et al.  Novel insights into G protein and G protein-coupled receptor signaling in cancer. , 2014, Current opinion in cell biology.

[11]  B. Engelhardt,et al.  DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation , 2014, Brain : a journal of neurology.

[12]  Martin Fussenegger,et al.  An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. , 2013, Biotechnology advances.

[13]  P. Mombaerts,et al.  Temporal patterns of odorant receptor gene expression in adult and aged mice , 2013, Molecular and Cellular Neuroscience.

[14]  Arthur Christopoulos,et al.  Emerging paradigms in GPCR allostery: implications for drug discovery , 2013, Nature Reviews Drug Discovery.

[15]  R. Abagyan,et al.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases. , 2013, Annual review of pharmacology and toxicology.

[16]  Quin F. Wills,et al.  Methods for qPCR gene expression profiling applied to 1440 lymphoblastoid single cells , 2013, Methods.

[17]  I. Laher,et al.  Emerging role of G protein-coupled receptors in microvascular myogenic tone. , 2012, Cardiovascular research.

[18]  Bin Zheng,et al.  KLF5 and hhLIM cooperatively promote proliferation of vascular smooth muscle cells , 2012, Molecular and Cellular Biochemistry.

[19]  P. Insel,et al.  GPCR expression in tissues and cells: Are the optimal receptors being used as drug targets? , 2012, British journal of pharmacology.

[20]  Evelien Vaes,et al.  Regulation of the Probability of Mouse Odorant Receptor Gene Choice , 2011, Cell.

[21]  C. Mack.  Signaling mechanisms that regulate smooth muscle cell differentiation. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A. Eckhart,et al.  Regulation of GPCR signaling in hypertension. , 2010, Biochimica et Biophysica Acta.

[23]  N. Morrell,et al.  Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[24]  J. He,et al.  Absence of the Adenosine A2A Receptor Confers Pulmonary Arterial Hypertension and Increased Pulmonary Vascular Remodeling in Mice , 2010, Journal of Vascular Research.

[25]  B. Blackman,et al.  Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis , 2009, Journal of Vascular Research.

[26]  Graziano Pesole,et al.  Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes , 2009, Nucleic Acids Res..

[27]  L. Journot,et al.  Identification of Potential Pharmacological Targets by Analysis of the Comprehensive G Protein-Coupled Receptor Repertoire in the Four Cardiac Chambers , 2009, Molecular Pharmacology.

[28]  S. Coughlin,et al.  Anatomical Profiling of G Protein-Coupled Receptor Expression , 2008, Cell.

[29]  N. Nakamura,et al.  Gene expression profiling of neuropeptides in mouse cerebellum, hippocampus, and retina. , 2008, Nutrition.

[30]  E. Larsson,et al.  Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[31]  M. Opp,et al.  Modeling sepsis in the laboratory: merging sound science with animal well-being. , 2008, Comparative medicine.

[32]  T. Callis,et al.  Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progression , 2008, Proceedings of the National Academy of Sciences.

[33]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[34]  P. Insel,et al.  Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets. , 2007, Biochimica et biophysica acta.

[35]  H. Rockman,et al.  Cardiac GPCRs: GPCR signaling in healthy and failing hearts. , 2007, Biochimica et biophysica acta.

[36]  H. Michel,et al.  Enhancing functional production of G protein‐coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen , 2006, Protein science : a publication of the Protein Society.

[37]  P. Carmeliet,et al.  VE‐Cadherin‐Cre‐recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[38]  L. Poston,et al.  Enhanced Vascular Responses to Adrenomedullin in Mice Overexpressing Receptor-Activity–Modifying Protein 2 , 2006, Circulation Research.

[39]  P. Clifford,et al.  Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles. , 2005, Journal of applied physiology.

[40]  Stefan Offermanns,et al.  Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.

[41]  P. Deng,et al.  Calcitonin gene-related peptide and hypertension , 2005, Peptides.

[42]  G. Owens,et al.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease. , 2004, Physiological reviews.

[43]  Alan Wise,et al.  The identification of ligands at orphan G-protein coupled receptors. , 2004, Annual review of pharmacology and toxicology.

[44]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[45]  Y. Hakak,et al.  Global analysis of G‐protein‐coupled receptor signaling in human tissues , 2003, FEBS letters.

[46]  Qingbo Xu,et al.  Activation of heat shock transcription factor 1 in atherosclerosis. , 2003, The American journal of pathology.

[47]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Ley,et al.  Adhesion molecules and atherogenesis. , 2001, Acta physiologica Scandinavica.

[49]  G. Gabbiani,et al.  Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[50]  K. Kangawa,et al.  Rat Aortic Smooth‐Muscle Cell Proliferation Is Bidirectionally Regulated in a Cell Cycle‐Dependent Manner via PACAP/VIP Type 2 Receptor a , 1998, Annals of the New York Academy of Sciences.

[51]  H. Ehrenreich,et al.  Characterization of the relaxant action of urocortin, a new peptide related to corticotropin‐releasing factor in the rat isolated basilar artery , 1998, British journal of pharmacology.

[52]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[53]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Ramachandran,et al.  Structure and Function of G Protein Coupled Receptors , 1990, Pharmaceutical Research.

[55]  J. Fleming,et al.  Control of the renal microvasculature by vasoactive peptides 1 , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  J. Thompson,et al.  Parathyroid hormone as a smooth muscle relaxant. , 1989, Endocrine reviews.

[57]  S. Chien,et al.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.

[58]  Stefan Offermanns,et al.  G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension , 2008, Nature Medicine.

[59]  A. Malik,et al.  Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.

[60]  G. Van Assche,et al.  Region-specific antiproliferative effect of VIP and PACAP-(1-38) on rabbit enteric smooth muscle. , 1999, American journal of physiology. Gastrointestinal and liver physiology.